ABSTRACT
Large-scale vector control campaigns have successfully reduced infectious disease incidence around the world. In addition to preventing new infections, these campaigns produce a wealth of information about the distribution and density of insect vectors, which can be incorporated into risk maps. These maps can effectively communicate risk map data to technicians on the ground, although encouraging them to use the data remains a challenge. We carried out a series of rolling trials in which we evaluated risk map use under different incentive schemes. Participants in the studies were trained field technicians tasked with house-to-house surveillance for insect vectors of Chagas disease in Arequipa, Peru. A novel incentive scheme based on poker best achieved a dual objective: to encourage technicians to preferentially visit higher-risk houses while surveilling evenly across the search zone. The poker incentive structure may be well-suited to improve entomological surveillance activities and other complex multi-objective tasks.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the National Institute of Health Grant NIH-NIAID 1R01AI101229-01A1
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All participants provided written informed consent to participate in the study. The study was approved by the institutional review boards of the University of Pennsylvania (protocol number 824603) and the Universidad Peruana Cayetano Heredia (protocol number 66427).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All relevant data are within the paper and its Supporting Information files. A public repository with tools and code used in the app with the added triangulation feature is available in the following public repository: https://github.com/chirimacha/VectorPoint-Triangulation. Code for statistical analyses and relevant data for reproducibility is also located in the repository.
